Eletriptan Pensa
Serotonin receptor agonist (triptan) for acute migraine treatment
Eletriptan Pensa contains eletriptan, a selective serotonin receptor agonist (triptan) used to treat acute migraine headaches in adults, with or without aura. This prescription medication works by constricting blood vessels in the brain and blocking pain pathways. This comprehensive guide covers dosage, side effects, drug interactions, contraindications, and safe use based on international medical guidelines.
Quick Facts
Key Takeaways
- Eletriptan Pensa is a prescription triptan used to treat acute migraine attacks in adults — it is not for migraine prevention or other types of headache.
- The recommended starting dose is 40 mg (two 20 mg tablets); a second dose may be taken after 2 hours if symptoms return, but do not exceed 80 mg in 24 hours.
- Do not use if you have cardiovascular disease, uncontrolled high blood pressure, severe liver or kidney problems, or a history of stroke.
- Never combine with ergotamine-type medications or other triptans within 24 hours due to risk of serious cardiovascular events.
- Common side effects include dizziness, drowsiness, nausea, and chest tightness — seek immediate medical help for chest pain, breathing difficulty, or signs of allergic reaction.
What Is Eletriptan Pensa and What Is It Used For?
Eletriptan Pensa belongs to a class of medications known as serotonin receptor agonists, commonly referred to as triptans. Serotonin (5-hydroxytryptamine, or 5-HT) is a naturally occurring neurotransmitter in the brain that plays a key role in regulating vascular tone, pain perception, and inflammation. During a migraine attack, certain blood vessels in the brain become abnormally dilated, and eletriptan works by selectively stimulating 5-HT1B and 5-HT1D receptors, causing these vessels to constrict back to their normal state.
Migraine is a complex neurological condition that affects approximately 12% of the global population, making it one of the most common disabling disorders worldwide according to the World Health Organization (WHO). Migraine attacks can last from 4 to 72 hours and are typically characterized by moderate to severe unilateral (one-sided) headache, often accompanied by nausea, vomiting, and sensitivity to light and sound. Some patients experience an aura phase before the headache begins, which may include visual disturbances (such as flashing lights or blind spots), numbness, tingling, or speech difficulties.
Eletriptan Pensa is indicated exclusively for the acute treatment of migraine attacks. It should be taken during the headache phase of the migraine, not during the aura phase or as a preventive measure. Unlike daily preventive medications (such as beta-blockers or antiepileptic drugs), triptans are designed to abort an individual migraine attack once it has begun. Clinical studies have demonstrated that eletriptan provides significant pain relief within 2 hours of administration in a majority of patients, with sustained headache response rates of approximately 65–77% at 24 hours.
It is important to understand that Eletriptan Pensa treats the symptoms of migraine but does not cure the underlying condition. If you experience frequent migraines (more than 4 attacks per month), your doctor may recommend a preventive treatment strategy in addition to acute treatments like eletriptan. Overuse of acute migraine medications, including triptans, can paradoxically lead to medication-overuse headache (MOH), a condition in which headaches become more frequent and severe with repeated use of pain-relief medications.
What Should You Know Before Taking Eletriptan Pensa?
Contraindications
Before starting treatment with Eletriptan Pensa, it is essential to discuss your complete medical history with your healthcare provider. There are several conditions in which this medication must not be used:
- You are allergic to eletriptan or any of the other ingredients in the tablet (see ingredients section below)
- You have severe liver or kidney disease
- You have moderate to severe hypertension (high blood pressure) or untreated mild hypertension
- You have a history of heart problems, including heart attack, angina, heart failure, or significant cardiac arrhythmias
- You have experienced coronary artery vasospasm (temporary narrowing of the heart's coronary arteries)
- You have peripheral vascular disease (poor circulation in the limbs)
- You have had a stroke or transient ischemic attack (TIA, also known as a mini-stroke)
- You have taken ergotamine or ergotamine-type medications (e.g., methysergide) within the past 24 hours
- You are currently taking another triptan (e.g., sumatriptan, rizatriptan, naratriptan, zolmitriptan, almotriptan, or frovatriptan)
Warnings and Precautions
Certain patient groups require careful evaluation before using Eletriptan Pensa. If any of the following apply to you, discuss the risks and benefits with your doctor before starting treatment:
- Diabetes mellitus — increased cardiovascular risk
- Smoking or nicotine replacement therapy — contributes to vascular disease
- Men over 40 years of age — higher cardiovascular risk profile
- Postmenopausal women — increased cardiovascular risk
- Family history of coronary artery disease — may indicate genetic predisposition
If you have been told that you are at increased risk of heart disease, do not use Eletriptan Pensa without first consulting your doctor. Your physician may recommend cardiovascular evaluation before initiating triptan therapy, particularly if you have multiple risk factors for coronary artery disease.
Eletriptan Pensa is not recommended for children and adolescents under 18 years of age due to insufficient safety and efficacy data. It is also not recommended for patients over 65 years of age, as there is limited clinical experience in this age group and older adults may be more susceptible to cardiovascular adverse effects.
Medication-Overuse Headache
Repeated and prolonged use of eletriptan or any other acute migraine medication over days or weeks can lead to daily chronic headaches. This condition, known as medication-overuse headache (MOH), may require you to discontinue the medication temporarily under medical supervision. If you notice that your headaches are becoming more frequent or that you are needing to take migraine medication more often, inform your doctor promptly.
Pregnancy and Breastfeeding
If you are pregnant, breastfeeding, think you may be pregnant, or are planning to have a baby, consult your doctor or pharmacist before using Eletriptan Pensa.
Pregnancy: Eletriptan Pensa should only be used during pregnancy if your doctor considers the potential benefit justifies the potential risk to the fetus. The safety of eletriptan in pregnant women has not been established through adequate and well-controlled studies. Animal studies have not shown direct teratogenic effects, but there is limited human data available.
Breastfeeding: Eletriptan is excreted in human breast milk. To minimize infant exposure, it is recommended to avoid breastfeeding for 24 hours after taking this medication. During this period, expressed breast milk should be discarded.
Driving and Operating Machinery
Both migraine itself and Eletriptan Pensa may cause drowsiness and dizziness, which can impair your ability to drive or operate machinery safely. You should avoid these activities during a migraine attack and after taking this medication until you understand how it affects you personally. Individual responses can vary significantly between patients.
Eletriptan Pensa 20 mg tablets contain lactose (a type of sugar) — if you have been told you are intolerant to certain sugars, consult your doctor before taking this medicine. The tablets also contain sunset yellow (E110), a coloring agent that may cause allergic reactions in some individuals. The tablets contain less than 1 mmol (23 mg) sodium per tablet, meaning they are essentially sodium-free.
How Does Eletriptan Pensa Interact with Other Drugs?
Drug interactions can alter how Eletriptan Pensa works or increase the risk of serious side effects. It is critically important to inform your doctor or pharmacist about all medications you are currently taking, have recently taken, or might take, including prescription drugs, over-the-counter medications, and herbal products. Some interactions are potentially life-threatening and require absolute avoidance of concomitant use.
Major Interactions (Contraindicated Combinations)
| Drug / Drug Class | Risk | Recommendation |
|---|---|---|
| Ergotamine & ergot derivatives (e.g., methysergide, dihydroergotamine) | Prolonged vasospasm, risk of ischemia | Do not use within 24 hours before or after eletriptan |
| Other triptans (sumatriptan, rizatriptan, naratriptan, zolmitriptan, almotriptan, frovatriptan) | Additive vasoconstrictive effects | Do not combine; use only one triptan per attack |
| Ketoconazole & itraconazole (antifungals) | Significantly increased eletriptan levels via CYP3A4 inhibition | Contraindicated; do not use together |
| HIV protease inhibitors (ritonavir, indinavir, nelfinavir) | Markedly increased eletriptan exposure via CYP3A4 inhibition | Contraindicated; do not use together |
Moderate Interactions (Use with Caution)
| Drug / Drug Class | Risk | Recommendation |
|---|---|---|
| Macrolide antibiotics (erythromycin, clarithromycin, josamycin) | Increased eletriptan levels via moderate CYP3A4 inhibition | Use with caution; consider lower dose |
| SSRIs (citalopram, fluoxetine, sertraline, etc.) | Risk of serotonin syndrome | Monitor for symptoms; consult doctor before combining |
| SNRIs (venlafaxine, duloxetine) | Risk of serotonin syndrome | Monitor for symptoms; consult doctor before combining |
| St. John's Wort (Hypericum perforatum) | Altered eletriptan metabolism; potential serotonergic effects | Do not take concurrently; consult doctor before stopping St. John's Wort |
When eletriptan is used together with SSRIs or SNRIs (commonly prescribed for depression and anxiety), there is a risk of developing serotonin syndrome, a potentially life-threatening condition. Symptoms include restlessness, hallucinations, loss of coordination, rapid heartbeat, elevated body temperature, rapid changes in blood pressure, and overactive reflexes. Seek immediate medical attention if you experience any of these symptoms while taking eletriptan with serotonergic medications.
What Is the Correct Dosage of Eletriptan Pensa?
Always use Eletriptan Pensa exactly as your doctor has instructed. If you are unsure, consult your doctor or pharmacist. The dosage may vary depending on individual response, kidney function, and other factors. Do not adjust your dose without medical guidance.
Adults
Standard Dosing
- Starting dose: 40 mg (two 20 mg tablets) taken at the onset of migraine headache
- Timing: Take during the headache phase, not during the aura phase
- Administration: Swallow tablets whole with water; may be taken with or without food
- If no response: Do not take a second dose for the same attack
- If headache returns: A second dose of 40 mg may be taken, but not sooner than 2 hours after the first dose
- Maximum daily dose: 80 mg (four 20 mg tablets) within any 24-hour period
If you find that one 40 mg dose does not adequately relieve your migraine, speak with your doctor. Your physician may consider increasing the dose to 80 mg as the initial dose for future attacks. The optimal dose should be determined through a careful assessment of individual response and tolerability.
| Patient Group | Starting Dose | Max Daily Dose | Notes |
|---|---|---|---|
| Adults (18–65 years) | 40 mg | 80 mg | Standard dosing; take at migraine onset |
| Mild–moderate renal impairment | 20 mg | 40 mg | Reduced dose; monitor response |
| Mild–moderate hepatic impairment | 40 mg | 80 mg | No dose adjustment needed |
| Children (<18 years) | N/A | N/A | Not recommended |
| Elderly (>65 years) | N/A | N/A | Not recommended; limited data |
Missed Dose
Eletriptan Pensa is taken only when needed during a migraine attack, so there is no regular dosing schedule. If you forget to take a dose during an attack, take it as soon as you remember, provided the migraine headache is still present. Do not take a double dose to make up for a missed one. If the headache has resolved on its own, there is no need to take the medication.
Overdose
If you have taken more Eletriptan Pensa than prescribed, or if a child has accidentally ingested the medication, contact your doctor, hospital emergency department, or poison control center immediately. Bring the medication packaging with you regardless of whether any tablets remain. Symptoms of overdose may include elevated blood pressure and cardiovascular complications. There is no specific antidote for eletriptan overdose; treatment is supportive and symptomatic.
What Are the Side Effects of Eletriptan Pensa?
Like all medications, Eletriptan Pensa can cause side effects, although not everyone experiences them. Most side effects are mild to moderate and resolve on their own within a few hours. However, some side effects can be serious and require immediate medical attention.
- Chest pain or tightness — may be intense and felt in the throat; could indicate ischemic heart disease, coronary artery spasm, or heart attack
- Sudden weakness on one side of the body, speech difficulties, or difficulty raising both arms — may indicate a stroke
- Allergic reactions — sudden wheezing, breathing difficulty, swelling of eyelids, face or lips, rash or itching (especially spreading over the whole body)
- Serotonin syndrome — restlessness, hallucinations, coordination problems, rapid heartbeat, elevated body temperature, overactive reflexes
- Intestinal ischemia — bloody diarrhea, abdominal pain, or vomiting
Common Side Effects
May affect up to 1 in 10 people
- Dizziness, vertigo, headache, drowsiness
- Reduced sensation of touch or pain (hypoesthesia)
- Chest pain, tightness, or pressure; palpitations; increased heart rate
- Sore throat, throat tightness, dry mouth
- Abdominal pain, indigestion, nausea
- Muscle stiffness, weakness, back pain, muscle aches
- General weakness, flushing, sweating, chills
- Tingling or abnormal sensations (paraesthesia)
- Runny nose, generalized pain
Uncommon Side Effects
May affect up to 1 in 100 people
- Breathing difficulty, yawning
- Swelling of face, hands, or feet; tongue inflammation; rash; itching
- Increased sensitivity to touch (hyperaesthesia); coordination problems; tremor; speech disturbance
- Depersonalization, depression, unusual thoughts, agitation, confusion, mood swings (euphoria), drowsiness (lethargy), insomnia
- Loss of appetite (anorexia), taste changes, thirst
- Osteoarthritis, bone pain, joint pain
- Increased urination frequency, urinary problems
- Visual disturbances, eye pain, sensitivity to light, dry or watery eyes
- Ear pain, tinnitus (ringing in the ears)
- Poor circulation (peripheral vascular disturbance)
- Diarrhea
Rare Side Effects
May affect up to 1 in 1,000 people
- Shock, asthma, urticaria (hives), skin changes, swollen tongue
- Throat or chest infection, swollen lymph nodes
- Slow heart rate (bradycardia)
- Emotional disturbance, mood changes
- Arthritis, muscle disorder, muscle twitching
- Constipation, esophageal inflammation (esophagitis), belching
- Breast pain, heavy or prolonged menstruation
- Eye infection (conjunctivitis), voice changes
- Fainting (syncope)
Other reported side effects include elevated blood pressure. Your doctor may also monitor your liver enzyme levels, bilirubin levels, or other blood parameters during treatment with eletriptan.
Reporting suspected adverse reactions after the medication has been authorized is important for ongoing monitoring of its benefit–risk balance. Healthcare professionals and patients are encouraged to report any suspected adverse reactions to their national pharmacovigilance authority.
How Should You Store Eletriptan Pensa?
Proper storage of medications is essential to maintain their effectiveness and safety throughout their shelf life. Eletriptan Pensa does not require any special storage conditions, making it convenient to store at home or carry when traveling.
- Temperature: Store at room temperature. No specific temperature requirements.
- Children: Keep out of the sight and reach of children at all times.
- Expiry date: Do not use after the expiry date (EXP) stated on the carton or blister. The expiry date refers to the last day of that month.
- Disposal: Do not throw medications in household waste or down the drain. Ask your pharmacist how to dispose of medications that are no longer needed. These measures help protect the environment.
When traveling, keep Eletriptan Pensa in its original packaging to protect the tablets from moisture and to have the product information readily available. There is no need for refrigeration or protection from light under normal storage conditions.
What Does Eletriptan Pensa Contain?
Understanding the composition of your medication is important, particularly if you have known allergies or intolerances to specific ingredients. Eletriptan Pensa contains both an active ingredient that provides the therapeutic effect and several inactive ingredients (excipients) that serve as structural and functional components of the tablet.
Active Ingredient
Each film-coated tablet contains eletriptan hydrobromide equivalent to 20 mg of eletriptan. Eletriptan hydrobromide is the salt form of eletriptan that allows for stable formulation and reliable absorption in the gastrointestinal tract.
Inactive Ingredients (Excipients)
Tablet core: Microcrystalline cellulose, anhydrous lactose, croscarmellose sodium, magnesium stearate.
Film coating: Titanium dioxide (E171), talc (E553b), sunset yellow aluminium lake (E110), soya lecithin (E322), xanthan gum (E415).
Tablet Appearance
Eletriptan Pensa 20 mg tablets are round (6.4 mm), biconvex, orange, film-coated tablets imprinted with "M" on one side and "EL1" on the other side.
Pack Sizes
Eletriptan Pensa is available in blister packs containing 3, 4, 6, 6 × 1, 18, or 20 film-coated tablets. Not all pack sizes may be marketed in all countries.
Frequently Asked Questions About Eletriptan Pensa
Eletriptan Pensa contains eletriptan, one of several triptans available for migraine treatment. While all triptans work by the same mechanism (stimulating 5-HT1B/1D receptors), they differ in their pharmacokinetic properties such as speed of onset, duration of action, and bioavailability. Eletriptan has a relatively fast onset (approximately 1–2 hours) and a longer half-life than some other triptans (approximately 4 hours), which may reduce the likelihood of headache recurrence. The choice of triptan should be made by your doctor based on your individual response and medical history.
No. Eletriptan Pensa is approved only for the treatment of migraine headaches in adults. It has not been shown to be effective for tension-type headaches, cluster headaches, or other types of headaches. Using it for non-migraine headaches may expose you to unnecessary side effects without providing benefit. If you are unsure whether your headaches are migraines, consult your doctor for an accurate diagnosis.
Generally, yes. Simple analgesics like paracetamol (acetaminophen) and non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen are not known to have clinically significant interactions with eletriptan. Some patients find that combining a triptan with an NSAID provides better migraine relief than either drug alone. However, always check with your doctor or pharmacist before combining medications, and be mindful of the risk of medication-overuse headache with frequent use of any acute migraine treatment.
Eletriptan typically begins to take effect within 30 minutes to 1 hour after ingestion, with maximum plasma concentrations reached in approximately 1.5 hours. Clinical studies show significant pain relief in the majority of patients within 2 hours of taking a 40 mg dose. The full therapeutic benefit may not be apparent until 2 hours after administration. If your headache does not improve at all after the first dose, do not take a second dose for that same attack.
While there is no specific contraindication for alcohol use with eletriptan, alcohol can worsen migraine symptoms and may increase the drowsiness and dizziness caused by the medication. Additionally, alcohol is a common migraine trigger for many people. It is generally advisable to avoid alcohol during a migraine attack and while taking eletriptan. If you have questions about alcohol and your migraine treatment, discuss them with your healthcare provider.
The safety of eletriptan during pregnancy has not been fully established. There is limited clinical data from pregnant women. Eletriptan Pensa should only be used during pregnancy if your doctor determines that the potential benefit outweighs the potential risk to the unborn baby. If you are pregnant or planning to become pregnant, discuss alternative migraine management strategies with your healthcare provider. If you are breastfeeding, avoid nursing for at least 24 hours after taking this medication.
Medical References and Sources
This article is based on current medical research and international guidelines. All claims are supported by scientific evidence from peer-reviewed sources.
- European Medicines Agency (EMA). "Eletriptan — Summary of Product Characteristics." EMA product database. European regulatory assessment and approved prescribing information for eletriptan.
- Goadsby PJ, et al. (2002). "Eletriptan in acute migraine: a double-blind, placebo-controlled comparison to sumatriptan." Neurology. 59(8):1210–1217. Randomized controlled trial comparing eletriptan efficacy to sumatriptan. Evidence level: 1B.
- World Health Organization (WHO). "Headache disorders: Key facts." WHO Fact Sheet, updated 2023. Global epidemiology and burden of migraine and headache disorders.
- National Institute for Health and Care Excellence (NICE). "Headaches in over 12s: diagnosis and management." Clinical Guideline CG150, updated 2021. UK national guidelines on the diagnosis and acute treatment of migraine in adults.
- Landy S, et al. (2004). "Efficacy, safety, and tolerability of eletriptan 40 mg: a meta-analysis." Headache. 44(6):572–580. Meta-analysis evaluating the overall efficacy and safety profile of eletriptan 40 mg across multiple RCTs. Evidence level: 1A.
- American Headache Society (AHS). "Evidence-based guidelines for migraine headache in the primary care setting: pharmacological management for acute attacks." Updated 2020. US guidelines for acute migraine pharmacotherapy in primary care.
- British National Formulary (BNF). "Eletriptan." BNF Monograph, reviewed 2025. Comprehensive drug monograph with UK prescribing and dispensing information.
Evidence grading: This article uses the GRADE framework (Grading of Recommendations Assessment, Development and Evaluation) for evidence-based medicine. Evidence level 1A represents the highest quality of evidence, based on systematic reviews of randomized controlled trials.
iMedic Editorial Standards
Peer Review Process
All medical content is reviewed by at least two licensed specialist physicians before publication.
Fact-Checking
All medical claims are verified against peer-reviewed sources and international guidelines.
Update Frequency
Content is reviewed and updated at least every 12 months or when new research emerges.
Corrections Policy
Any errors are corrected immediately with transparent changelog.
Medical Editorial Board: iMedic has an independent medical editorial board consisting of specialist physicians in neurology, clinical pharmacology, and internal medicine.